[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Donald E. Bobo, Jr net worth and biography

Donald Bobo, Jr Biography and Net Worth

VP of Edwards Lifesciences

Donald E. Bobo, Jr., has been corporate vice president since 2007 and is currently responsible for the company’s corporate strategy and corporate development functions. In addition, Bobo has executive responsibility for disease awareness and heart failure initiatives as well as the healthcare solutions and commercial services team. Bobo has more than 30 years of experience in the medical products and healthcare industry in various leadership roles at Edwards including, most recently, the development of the company’s Transcatheter Mitral and Tricuspid Therapies organization, vice president and general manager of the Surgical Structural Heart business and global valve manufacturing operations. Prior to joining Edwards, Bobo held a variety of roles with increasing levels of responsibilities with American Hospital Supply and Baxter Healthcare, including research and development, business development, operations and general management. He has served as board chairman of the California Life Sciences Association (CLSA). Bobo received a bachelor's degree in mathematics from Bob Jones University, and a master's degree in engineering from the University of Southern California.

What is Donald E. Bobo, Jr's net worth?: The estimated net worth of Donald E. Bobo, Jr is at least $3.26 million as of November 13th, 2024. Mr. Bobo, Jr owns 46,936 shares of Edwards Lifesciences stock worth more than $3,263,929 as of November 21st. This net worth evaluation does not reflect any other assets that Mr. Bobo, Jr may own. Learn More about Donald E. Bobo, Jr's net worth.
How do I contact Donald E. Bobo, Jr?: The corporate mailing address for Mr. Bobo, Jr and other Edwards Lifesciences executives is ONE EDWARDS WAY, IRVINE CA, 92614. Edwards Lifesciences can also be reached via phone at (949) 250-2500 and via email at [email protected]. Learn More on Donald E. Bobo, Jr's contact information.
Has Donald E. Bobo, Jr been buying or selling shares of Edwards Lifesciences?: Over the course of the past ninety days, Donald E. Bobo, Jr has sold $675,400.00 in Edwards Lifesciences stock. Most recently, Donald E. Bobo, Jr. sold 5,000 shares of the business's stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $65.57, for a transaction totalling $327,850.00. Following the completion of the sale, the vice president now directly owns 46,936 shares of the company's stock, valued at $3,077,593.52. Learn More on Donald E. Bobo, Jr's trading history.
Who are Edwards Lifesciences' active insiders?: Edwards Lifesciences' insider roster includes Donald Bobo, Jr (VP), Daveen Chopra (VP), Kieran Gallahue (Director), Leslie Heisz (Director), Jean-Luc Lemercier (VP), Daniel Lippis (VP), Martha Marsh (Director), Michael Mussallem (CEO), Robert Sellers (VP), Catherine Szyman (VP), Scott Ullem (CFO), Nicholas Valeriani (Director), Huimin Wang (VP), Larry Wood (VP), and Bernard Zovighian (VP). Learn More on Edwards Lifesciences' active insiders.
Are insiders buying or selling shares of Edwards Lifesciences?: In the last year, Edwards Lifesciences insiders bought shares 1 times. They purchased a total of 580 shares worth more than $49,729.20. In the last year, insiders at the medical research company sold shares 38 times. They sold a total of 431,721 shares worth more than $35,433,938.52. The most recent insider tranaction occured on November, 13th when VP Donald E Bobo Jr sold 5,000 shares worth more than $327,850.00. Insiders at Edwards Lifesciences own 1.3% of the company. Learn More about insider trades at Edwards Lifesciences.
Information on this page was last updated on 11/13/2024.

Donald E. Bobo, Jr Insider Trading History at Edwards Lifesciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/13/2024	Sell	5,000	$65.57	$327,850.00	46,936
10/15/2024	Sell	5,000	$69.51	$347,550.00	46,936
9/11/2024	Sell	5,000	$66.77	$333,850.00	46,936
8/14/2024	Sell	5,000	$66.08	$330,400.00	46,936
7/10/2024	Sell	5,000	$93.29	$466,450.00	46,936
6/12/2024	Sell	5,000	$87.54	$437,700.00	46,936
5/10/2024	Sell	5,000	$87.81	$439,050.00	47,750
3/13/2024	Sell	14,500	$91.01	$1,319,645.00	39,503
2/13/2024	Sell	11,000	$85.83	$944,130.00	39,503
1/12/2024	Sell	10,000	$75.67	$756,700.00	39,503
12/13/2023	Sell	8,000	$71.86	$574,880.00	39,503
11/13/2023	Sell	6,000	$65.30	$391,800.00	39,503
10/13/2023	Sell	5,000	$69.98	$349,900.00	39,503
9/14/2023	Sell	4,500	$73.71	$331,695.00	39,503
8/14/2023	Sell	4,500	$79.30	$356,850.00	39,503
7/14/2023	Sell	3,500	$92.94	$325,290.00	39,503
5/5/2023	Sell	5,635	$88.62	$499,373.70	56,225
4/6/2023	Sell	6,725	$83.09	$558,780.25	62,824
2/6/2023	Sell	6,725	$80.75	$543,043.75	62,561
1/9/2023	Sell	6,725	$77.50	$521,187.50	62,561
12/12/2022	Sell	6,725	$74.32	$499,802.00	62,561
11/8/2022	Sell	6,725	$68.46	$460,393.50	62,561
10/10/2022	Sell	6,725	$85.00	$571,625.00	62,561
10/10/2022	Sell	6,725	$85.00	$571,625.00	62,561
9/8/2022	Sell	6,725	$90.94	$611,571.50	62,561
7/8/2022	Sell	6,725	$97.60	$656,360.00	62,561
6/13/2022	Sell	6,725	$90.02	$605,384.50	62,561
4/8/2022	Sell	11,050	$123.34	$1,362,907.00	152,326
3/11/2022	Sell	11,050	$106.00	$1,171,300.00
2/11/2022	Sell	11,050	$111.49	$1,231,964.50
1/28/2022	Sell	11,050	$101.15	$1,117,707.50
11/5/2021	Sell	11,050	$117.17	$1,294,728.50
10/8/2021	Sell	11,050	$110.49	$1,220,914.50
9/10/2021	Sell	11,050	$122.25	$1,350,862.50
8/6/2021	Sell	11,050	$114.37	$1,263,788.50	67,449
5/7/2021	Sell	11,050	$92.52	$1,022,346.00	63,895
3/12/2021	Sell	13,077	$82.85	$1,083,429.45	61,585
2/5/2021	Sell	13,077	$85.80	$1,122,006.60	61,585
1/8/2021	Sell	13,077	$90.45	$1,182,814.65	61,585
12/11/2020	Sell	13,074	$84.65	$1,106,714.10	61,582
11/13/2020	Sell	13,074	$80.56	$1,053,241.44	61,582
11/9/2020	Sell	227	$83.89	$19,043.03	48,508
11/6/2020	Sell	347	$78.01	$27,069.47	48,508
9/11/2020	Sell	13,074	$82.45	$1,077,951.30	61,582
8/6/2020	Sell	12,000	$77.28	$927,360.00	72,832
7/10/2020	Sell	13,074	$67.46	$881,972.04	85,906
5/15/2020	Sell	4,358	$215.16	$937,667.28	28,609
5/8/2020	Sell	5,372	$220.94	$1,186,889.68	22,447
4/3/2020	Sell	5,369	$182.44	$979,520.36	26,191
2/7/2020	Sell	5,369	$235.65	$1,265,204.85	26,082
1/10/2020	Sell	5,369	$235.69	$1,265,419.61	26,082
12/11/2019	Sell	5,369	$229.26	$1,230,896.94	26,082
11/8/2019	Sell	5,369	$234.37	$1,258,332.53	26,082
8/9/2019	Sell	5,369	$216.26	$1,161,099.94	26,082
7/29/2019	Sell	21,000	$211.92	$4,450,320.00	41,713
7/10/2019	Sell	5,369	$190.09	$1,020,593.21	26,082
5/30/2019	Sell	3,000	$169.60	$508,800.00	20,674
5/17/2019	Sell	5,369	$175.06	$939,897.14	26,043
5/8/2019	Sell	300	$178.54	$53,562.00	19,415
3/13/2019	Sell	5,500	$175.73	$966,515.00	24,482
2/13/2019	Sell	5,500	$177.75	$977,625.00	24,482
12/12/2018	Sell	5,500	$164.99	$907,445.00
10/10/2018	Sell	5,500	$147.50	$811,250.00	25,490
9/12/2018	Sell	5,500	$144.16	$792,880.00	25,490
8/31/2018	Sell	75	$144.24	$10,818.00	19,990
7/11/2018	Sell	5,500	$145.57	$800,635.00
6/13/2018	Sell	5,500	$150.00	$825,000.00	25,512
4/4/2018	Sell	4,000	$134.78	$539,120.00
3/29/2018	Sell	5,300	$138.58	$734,474.00	24,908
2/20/2018	Sell	5,300	$134.70	$713,910.00	24,908
2/12/2018	Sell	3,750	$127.54	$478,275.00	19,608
1/29/2018	Sell	5,300	$127.24	$674,372.00	24,908
12/28/2017	Sell	5,300	$114.08	$604,624.00
12/28/2017	Sell	5,300	$114.08	$604,624.00
11/29/2017	Sell	5,300	$116.45	$617,185.00
10/30/2017	Sell	5,300	$101.12	$535,936.00
9/29/2017	Sell	5,300	$108.86	$576,958.00
8/29/2017	Sell	5,300	$112.15	$594,395.00
8/4/2017	Sell	25,000	$116.00	$2,900,000.00
7/28/2017	Sell	5,300	$114.68	$607,804.00
6/29/2017	Sell	5,600	$117.15	$656,040.00
5/8/2017	Sell	19,100	$110.34	$2,107,494.00
5/4/2017	Sell	34,120	$109.98	$3,752,517.60
4/5/2017	Sell	13,720	$93.58	$1,283,917.60
3/6/2017	Sell	13,720	$90.01	$1,234,937.20
1/12/2017	Sell	13,720	$97.47	$1,337,288.40
11/2/2016	Sell	15,000	$90.13	$1,351,950.00
9/2/2016	Sell	18,000	$115.78	$2,084,040.00
5/31/2016	Sell	18,000	$99.04	$1,782,720.00	62,796
10/24/2014	Sell	30,000	$114.25	$3,427,500.00
10/3/2014	Sell	25,000	$105.00	$2,625,000.00
9/10/2014	Sell	25,000	$100.00	$2,500,000.00
7/30/2014	Sell	23,270	$92.00	$2,140,840.00
6/27/2014	Sell	25,000	$87.00	$2,175,000.00
10/4/2012	Sell	11,530	$110.14	$1,269,914.20

Donald E. Bobo, Jr Buying and Selling Activity at Edwards Lifesciences

Edwards Lifesciences Company Overview

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Today's Range

Now: $70.15

$69.16

$70.23

50 Day Range

MA: $67.61

$64.54

$70.63

2 Week Range

Now: $70.15

$58.93

$96.12

Volume

1,018,237 shs

Average Volume

4,637,770 shs

Market Capitalization

$41.37 billion

P/E Ratio

10.12

Dividend Yield

N/A

Beta

1.12